NET‐associated proteins, integrin‐αvβ1, and MMP‐9, synergistically capture and activate latent TGF‐β, which interacts with the TGFβR1 on cancer cells and promotes EMT as well as chemoresistance. This evidence concerns the gene TGFB1 and cancer.